{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-22-000116","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.651085+00:00","generated_at":"2026-06-21T21:45:58.555527+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Dentsply Sirona Q3 net sales $947M, GAAP EPS loss $5.01; FY22 adj. EPS cut to $1.90-$2.00","bullets":["Net sales down 8.9% to $947M; organic sales -0.7%; FX headwind of 8.2%.","GAAP net loss of $1,077M, or ($5.01) per diluted share, vs. $0.38 EPS in Q3 2021.","Adjusted EPS $0.41, down 31.5% YoY from $0.60; adjusted operating margin 14.7% vs 18.2%.","Updated FY22 outlook: organic sales decline ~2%; adj. EPS $1.90-$2.00 (previous $2.25-$2.45).","CEO cites macroeconomic headwinds; comprehensive business review initiated."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-22-000116","json":"https://secwatch.observer/filing/0000818479-22-000116.json","markdown":"https://secwatch.observer/filing/0000818479-22-000116.md","text":"https://secwatch.observer/filing/0000818479-22-000116.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000116/0000818479-22-000116-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000116/xray-20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T21:45:58.555527+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd301d549798ff5213016f6ddb32aad45ac0152c","claim":"DENTSPLY SIRONA Inc. reported the third quarter ended September 30, 2022 results: revenue $947 million, net income ($1,077) million, EPS ($5.01) loss per diluted share.","evidence_excerpt":"Charlotte, N.C., November 14, 2022 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the \"Company\") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2022. Third quarter net sales of $947 million decreased (8.9%), compared to $1,040 million in the third quarter of 2021. Foreign currency translation negatively impacted sales by (8.2%). Net loss for the third quarter of 2022 was ($1,077) million, or ($5.01) loss per diluted share, compared to $84 million, or $0.38 per diluted share in the third quarter of 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000116/0000818479-22-000116-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$947 million"},{"label":"Net income","value":"($1,077) million"},{"label":"EPS","value":"($5.01) loss per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}